Posts

Australia's economic growth slows to 0.2% in March quarter

Australia’s GDP rose by 0.2 per cent in Q1 2025 and 1.3 per cent year-on-year, r...

India’s Andhra Pradesh state to establish logistics cor...

India’s Andhra Pradesh state Chief Minister has asked officials to complete firs...

Courrèges’ Nicolas Di Felice calls on his community to ...

Courrèges’ creative director Nicolas Di Felice tapped into his community of muse...

Baby blue is the new red: Ferrari unveils capsule with ...

Ferrari unveiled a baby blue capsule collection with Formula 1 driver Charles Le...

UK's WH Smith posts Q3 sales rise on strong travel demand

WH Smith reported a 5% Q3 like-for-like revenue increase, with North America up ...

Tommy Hilfiger named as official apparel partner for Ca...

Tommy Hilfiger joins Cadillac Formula 1 Team Credits: Tommy Hilfiger Tomm...

First look: Nobody’s Child treads new ground with footw...

Drapers First look: Nobody’s Child treads new ground with footwear collection Pr...

Electricity consumer groups urge FERC to improve load f...

Load forecasts, which are surging, can affect wholesale electricity prices and r...

Think small: Why America should bet on small modular re...

To reach their potential, SMRs will require effective support across the entire ...

‘Putting profit over people’: big gas is waging war on ...

Coalition that includes SoCalGas, country’s largest gas utility, has launched fi...

IVF Media G5 - Procedural steps and scientific informat...

IVF Media G5 - Procedural steps and scientific information after initial consult...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Roclanda, latanoprost ...

After groundbreaking CRISPR therapy, a homecoming

And more biotech news, brought to you by The Readout.

How incarceration affects mortality — for people both i...

And other health news coming your way.

STAT+: FDA’s AI tool, Elsa, is here. ‘The stupidest big...

This is the web edition of STAT's AI Prognosis, our subscriber-exclusive newslet...

STAT+: Pharmalittle: We’re reading about Merck eyeing a...

Merck held talks over a potential $3 billion acquisition of MoonLake Immunothera...

CHMP opinions on consultation procedures

CHMP opinions on consultation procedures

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Beqvez (previously Dur...

Regeneron makes obesity push; Atai, Alto ink brain drug...

Regeneron licensed a weight loss drug and revealed study data for a pair of musc...

Vigil's rare brain disease drug flunks phase 2 study, b...

A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and...

Bayer's Vividion secures rights to world's only clinica...

Bayer’s Vividion Therapeutics has secured the global rights from its partner Roc...

Biosynthesis specialist and Narcan ingredient maker Ant...

Antheia, a biomanufacturer that makes a key ingredient for the opioid overdose t...

What Automotive Event Is Still On Your Bucket List?

Sound off in the comments with the single automotive event that you need to expe...

At $3,450, Is This 1994 Mitsubishi Diamante A Dimond In...

An extremely rare car, even when new, this Diamante wagon would be a hit at any...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.